Pharmaceutical, Webinars

Supporting Earlier Delivery-System Decisions Through a USP <382>-Aligned Approach

8 Sep 2026

Early delivery-system decisions can influence the success of injectable drug development programs. This article explores a USP <382>-aligned system-level approach developed by Aptar Pharma and Stevanato Group, evaluating prefilled syringe, plunger, and rigid needle shield configurations to generate performance and integrity

By Crystal Salvans, Aptar Pharma, Sara Masucci, Stevanato Group
$resourceAuthor.title, $resourceAuthor.title
Share
USP382_newsroom_header_safezone_1920x1080.jpg

Learn more about Aptar Pharma Expertise
in Injectable Drug Delivery

 

This Might Also Be of Interest

24 Jul 2026
Aptar Pharma x Dianosic: Innovating Intranasal Drug Delivery
Pharmaceutical Webinars
20 Jul 2026
NeuroSpray™: Precision Nose-to-Brain Drug Delivery Platform
Pharmaceutical Publications
29 May 2025
Overcoming Challenges in Preclinical Studies for Intranasal and Inhalation Programs
Pharmaceutical Webinars
05 Dec 2024
Optimising Preclinical Studies for Intranasal and Pulmonary Programmes
Pharmaceutical Publications